NYSE: WELLWelltower Inc Stock
$147.27+1.64 (+1.13%)
Updated Apr 17, 2025
WELL Price
$147.27
Fair Value Price
N/A
Market Cap
$94.45B
52 Week Low
$90.76
52 Week High
$158.55
P/E
93.21x
P/B
2.96x
P/S
9.51x
PEG
1.59x
Dividend Yield
0.91%
Revenue
$7.99B
Earnings
$951.68M
Gross Margin
39.6%
Operating Margin
19.13%
Profit Margin
11.9%
Debt to Equity
0.58
Operating Cash Flow
$2B
Beta
0.78
Next Earnings
Apr 28, 2025
Ex-Dividend
N/A
Next Dividend
N/A
WELL Overview
Welltower Incorporated, a real estate investment trust (REIT), partners with seniors housing operators, post-acute providers, and health systems to fund the health care real estate infrastructure. Known as Healthcare REIT until 2015, the company was founded in 1970 and is headquartered in Toledo, OH.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine WELL's potential to beat the market
CHold
- Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More
Zen Rating Component Grades
C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Healthcare Facility REIT
Industry Rating
C
WELL
Ranked#12 of 16
Ranked#12 of 16
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $67.93 | C | |
| $28.75 | C | |
| $10.97 | C |
Be the first to know about important WELL news, forecast changes, insider trades & much more!
WELL News
Overview
Due Diligence Score
–
Industry Average (27)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how WELL scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
WELL ($147.27) is trading above its intrinsic value of $40.68, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
WELL is poor value based on its earnings relative to its share price (93.21x), compared to the US market average (27.98x)
P/E vs Market Valuation
WELL is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 35 more WELL due diligence checks available for Premium users.
Valuation
WELL price to earnings (PE)
For valuing profitable companies with steady earnings
Company
93.21x
Industry
108.63x
Market
27.98x
WELL is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
WELL is poor value based... subscribe to Premium to read more.
P/E vs Market Valuation
WELL price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
2.96x
Industry
2.26x
WELL is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation
WELL price to earnings growth (PEG)
For valuing profitable companies with growth potential
WELL is poor value relative... subscribe to Premium to read more.
PEG Value Valuation
WELL's financial health
Profit margin
Revenue
$2.3B
Net Income
$120.0M
Profit Margin
5.3%
WELL's Earnings (EBIT) of $1.53B... subscribe to Premium to read more.
Interest Coverage Financials
WELL's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$51.0B
Liabilities
$18.5B
Debt to equity
0.58
WELL's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
WELL's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$559.2M
Investing
-$2.2B
Financing
$1.6B
WELL's operating cash flow ($2.26B)... subscribe to Premium to read more.
Debt Coverage Financials
WELL vs Healthcare Facility REIT Stocks
Welltower Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.